PLXS Plexus Corp

Plexus Corp. (NASDAQ:PLXS) has experienced a double-digit share price rise recently, bringing its valuation close to industry averages. While the share price appears sensible according to a price-to-earnings model, indicating it's not a bargain, the company's future outlook is positive with expected double-digit profit growth. Investors should consider the company's financial strength and other factors beyond just the PE ratio before making a decision.

This article provides a detailed stock analysis for Plexus Corp. (PLXS), highlighting a mid-channel oscillation pattern and a significant short setup with an exceptional 36.0:1 risk-reward ratio. It outlines three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, along with multi-timeframe signal analysis. The current sentiment for PLXS is largely neutral, with a strong near-term outlook that could influence mid and long-term perspectives.

Pacer Advisors Inc. significantly reduced its stake in Plexus Corp. by 45.9% in the third quarter, selling 69,114 shares and retaining 81,311 shares worth approximately $11.77 million. Despite this, Plexus (NASDAQ:PLXS) exceeded Q3 earnings and revenue estimates, reporting $2.14 EPS on $1.06 billion revenue, and received a consensus analyst rating of Hold with a $159 target. Institutional investors collectively own 94.45% of the company's stock, while insiders hold 1.76%.

Plexus (PLXS) gained 14.5% in the last six months, underperforming the industry and broader sector. While the company benefits from new program ramps in healthcare, aerospace, and industrial markets, and strong free cash flow, it faces headwinds from near-term challenges in the Industrial sector and customer concentration risks. Analysts have slightly lowered estimates, and the stock is currently a Zacks Rank #3 (Hold), suggesting a cautious approach for investors.

Wedge Capital Management L L P NC increased its stake in Plexus Corp. (NASDAQ:PLXS) by 36.6% in the third quarter, bringing its total to 27,600 shares valued at approximately $3.99 million. This move comes as institutional investors hold about 94% of Plexus shares, despite company insiders selling over $1.88 million worth of stock in the last three months. Plexus recently surpassed Q3 earnings and revenue estimates and analysts currently rate the stock as a "Hold" with an average target price of $159.00.

Plexus Corp. (NASDAQ:PLXS) has received an average rating of "Hold" from five brokerages, with three recommending "hold" and two recommending "buy." The consensus one-year price target is $159.00. Insider selling has occurred recently, with the CFO and a director offloading shares, while institutional investors hold a significant portion of the stock.